| 前收市價 | 16.16 |
| 開市 | 16.19 |
| 買盤 | 16.73 x 100 |
| 賣出價 | 16.81 x 100 |
| 今日波幅 | 16.19 - 16.91 |
| 52 週波幅 | 11.81 - 24.70 |
| 成交量 | |
| 平均成交量 | 560,567 |
| 市值 | 2.69B |
| Beta 值 (5 年，每月) | 1.63 |
| 市盈率 (最近 12 個月) | 無 |
| 每股盈利 (最近 12 個月) | -0.35 |
| 業績公佈日 | 2024年5月07日 |
| 遠期股息及收益率 | 無 (無) |
| 除息日 | 無 |
| 1 年預測目標價 | 19.72 |
ZacksPuma Biotechnology (PBYI) Soars 14.0%: Is Further Upside Left in the Stock?
Puma Biotechnology (PBYI) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Insider MonkeyCertara, Inc. (NASDAQ:CERT) Q4 2023 Earnings Call Transcript
Certara, Inc. (NASDAQ:CERT) Q4 2023 Earnings Call Transcript February 29, 2024 Certara, Inc. misses on earnings expectations. Reported EPS is $0.09 EPS, expectations were $0.11. CERT isn’t one of the 30 most popular stocks among hedge funds at the end of the third quarter (see the details here). Operator: Hello and thank you for standing […]
ZacksCertara, Inc. (CERT) Lags Q4 Earnings Estimates
Certara, Inc. (CERT) delivered earnings and revenue surprises of -18.18% and 1.40%, respectively, for the quarter ended December 2023. Do the numbers hold clues to what lies ahead for the stock?
